Cover Image

Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib

Saved in:

Bibliographic Details
Main Authors:	M. Pestana (Author), M. Brito Caldeira (Author), B. Duarte (Author)
Format:	Book
Published:	Elsevier, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Artículo traducido] Dermatitis atópica y alopecia areata multilocular tratadas simultáneamente con baricitinib
by: M. Pestana, et al.
Published: (2024)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

Alopecia areata treatment with baricitinib: different relapse phenotypes
by: Federica Dall'Oglio, et al.
Published: (2024)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

Therapeutic Response of Alopecia Areata-Associated Nail Changes to Baricitinib
by: Ashley Wittmer, et al.
Published: (2024)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
by: Sofia Faria, et al.
Published: (2023)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024)

Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis,
by: Viviane Maria Maiolini, et al.
Published: (2021)

Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective
by: A. Alshahrani, et al.
Published: (2024)

Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
by: Anthony A. Gaspari
Published: (2024)

Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024)

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
by: Maryanne M. Senna, et al.
Published: (2023)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
by: Diana Gruenstein, BA, et al.
Published: (2020)

Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report
by: Xin Yan, et al.
Published: (2023)

Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report
by: Hideaki Uchida, et al.
Published: (2019)

Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
by: Takafumi Numata, et al.
Published: (2024)

Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
by: Francisco Javier De la Torre-Gomar, et al.
Published: (2024)

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
by: Danielle Rogner, et al.
Published: (2022)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
by: Ana M. Montilla, et al.
Published: (2019)

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
by: Luigi Gargiulo, et al.
Published: (2023)

Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy
by: Antonio Costanzo, et al.
Published: (2023)

Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
by: Axel De Greef, et al.
Published: (2023)

Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023)

Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry
by: Celeste M. Boesjes, et al.
Published: (2022)

Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata,
by: Guilherme Muzy
Published: (2024)

Retrospective Analysis of the Effect of Comorbid Atopic Dermatitis on the Treatment Response to Topical Immunotherapy in Pediatric Alopecia Areata Patients
by: Ayşe Mine Gök, et al.
Published: (2024)

Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
by: Zoe Apalla, et al.
Published: (2024)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
by: Miguel Nogueira, et al.
Published: (2021)

Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
by: Núria Garrós, et al.
Published: (2023)

Agreement Between Self-reported and Dermatologists' Diagnosis for Alopecia Areata and Atopic Dermatitis: A Bi-centric Prospective Study
by: Marie-Aleth Richard, et al.
Published: (2019)

A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
by: Jiahui Zhao, PhD, MD, et al.
Published: (2022)

Alopecia areata
by: Chieh Chen
Published: (2023)

Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature review
by: Masahiro Fukuyama, et al.
Published: (2023)

Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
by: Brittany Craiglow, et al.
Published: (2024)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
by: Novin Nezamololama, et al.
Published: (2020)

Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
by: Robin C. Yi, et al.
Published: (2024)

Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
by: Susan Taylor, et al.
Published: (2023)

Baricitinib: First Systemic Oral Drug for Alopecia Therapy
by: Prashant Mishra, et al.
Published: (2022)

Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
by: Agatha Anindhita Ayu Ardhaninggar, et al.
Published: (2018)